JPRN-UMIN000048394招募中未知
Switching from existing anti-VEGF agents to ranibizumab BS in age-related macular degeneration - Switching from existing anti-VEGF agents to ranibizumab BS in AMD
agoya university0 个研究点目标入组 75 人开始时间: 2022年7月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 40years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with unstable drug administration intervals with TAE regimen using existing anti-VEGF drugs, patients with other concomitant ocular diseases such as active uveitis and proliferative diabetic retinopathy, patients who have undergone previous vitrectomy or treatment with unknown details at other hospitals, and patients for whom anterior chamber fluid sampling by anterior chamber puncture is deemed unsafe.
研究者
相似试验
已完成
不适用
Switch of anti-VEGF agents (Bevacizumab and Ranibizumab) in non-responders to anti-VEGF treatment in AMDH35.3Degeneration of macula and posterior poleDRKS00004918niversitäts-Augenklinik Freiburg435
进行中（未招募）
4 期
Switching from originator infliximab to biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving clinical remission (the IFX-SIRIUS study I): Study protocol for an interventional, multicenter, open-label, single-arm and noninferiority clinical trial with clinical, ultrasound and biomarker assessmentsRheumatoid arthritisJPRN-jRCTs071190030Kawakami Atsushi80
进行中（未招募）
1 期
Switching to aflibercept in patients with wet AMD not responding to anti-VEGF treatment.eovascular Age-related macular degenerationEUCTR2013-001208-12-NLRadboud University Nijmegen Medical Centre20
已完成
4 期
Switching to aflibercept in patients with neovascular AMD not responding to anti-VEGF treatment.10047060macular degenerationage-related macular degenerationNL-OMON38763niversitair Medisch Centrum Sint Radboud20
已完成
不适用
Clinical study in new protocol of anti-VEGF agents for macular edema with retinal vein occlusion and in relation between the protocol and cytokinesRetinal Vein OcclusionJPRN-UMIN000030311Tokyo medical university100